Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 60.0
(-8.95%)
TWD 60.0
(-8.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -33 Million TWD | -63.67% |
| 2022 | -20.16 Million TWD | -159.3% |
| 2021 | -7.77 Million TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -26.59 Million TWD | -48.89% |
| 2024 Q2 | -26.96 Million TWD | -1.38% |
| 2023 Q1 | -13.12 Million TWD | -129.55% |
| 2023 FY | - TWD | -63.67% |
| 2023 Q4 | -17.86 Million TWD | 0.0% |
| 2023 Q3 | -17.86 Million TWD | -36.13% |
| 2023 Q2 | -13.12 Million TWD | 0.0% |
| 2022 FY | - TWD | -159.3% |
| 2022 Q4 | -5.71 Million TWD | 0.0% |
| 2022 Q3 | -5.71 Million TWD | 0.0% |
| 2021 FY | - TWD | 0.0% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 28.626% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 108.386% |
| Level Biotechnology Inc. | 98.7 Million TWD | 133.439% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 26.225% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 54.231% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -30.805% |
| GlycoNex Incorporation | -126.82 Million TWD | 73.976% |
| VBI | -6.97 Million TWD | -373.408% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 77.031% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 251.334% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -86.201% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 68.146% |
| Visgeneer Inc. | 973 Thousand TWD | 3492.189% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 90.278% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 103.525% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 133.06% |
| Neith Corporation | -33.61 Million TWD | 1.797% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 96.67% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -1800.173% |
| Enimmune corporation | -228.96 Million TWD | 85.585% |
| TaiRx, Inc. | -208.64 Million TWD | 84.181% |
| CHO Pharma, Inc. | -277.73 Million TWD | 88.116% |
| EirGenix Inc. | -664.4 Million TWD | 95.032% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 144.661% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 147.736% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 96.919% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 70.819% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 194.741% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 47.056% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -25.498% |
| RBC Bioscience Corporation | 36.54 Million TWD | 190.311% |
| BiOptic Inc. | 65.03 Million TWD | 150.749% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 95.164% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 39.896% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 107.613% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 58.78% |
| NaviFUS Corp. | -55.79 Million TWD | 40.844% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -98.855% |
| Sinew Pharma Inc. | -163.63 Million TWD | 79.829% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 46.332% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 117.155% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 85.439% |
| AP Biosciences Inc | -325.51 Million TWD | 89.86% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 96.84% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 7.923% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 213.306% |
| Intech Biopharm Corporation | -219.58 Million TWD | 84.969% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 95.105% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 26.573% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 79.481% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 105.035% |
| TCI GENE Inc. | 25.98 Million TWD | 227.039% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 70.168% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 88.369% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 77.389% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 338.31% |
| PharmaEngine, Inc. | 347.3 Million TWD | 109.503% |
| Savior Lifetec Corporation | 219.6 Million TWD | 115.03% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 119.164% |
| OBI Pharma, Inc. | -855.08 Million TWD | 96.14% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 64.342% |
| Acepodia, Inc. | -764.51 Million TWD | 95.683% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 92.826% |